JP2016531949A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016531949A5 JP2016531949A5 JP2016546191A JP2016546191A JP2016531949A5 JP 2016531949 A5 JP2016531949 A5 JP 2016531949A5 JP 2016546191 A JP2016546191 A JP 2016546191A JP 2016546191 A JP2016546191 A JP 2016546191A JP 2016531949 A5 JP2016531949 A5 JP 2016531949A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- composition
- olopatadine
- mometasone
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 16
- JBIMVDZLSHOPLA-LSCVHKIXSA-N olopatadine Chemical compound C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 JBIMVDZLSHOPLA-LSCVHKIXSA-N 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 10
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 claims 9
- 229960004114 olopatadine Drugs 0.000 claims 9
- 201000010105 allergic rhinitis Diseases 0.000 claims 8
- 239000007921 spray Substances 0.000 claims 8
- 229960001664 mometasone Drugs 0.000 claims 7
- 206010039085 Rhinitis allergic Diseases 0.000 claims 6
- 239000012458 free base Substances 0.000 claims 4
- 208000024891 symptom Diseases 0.000 claims 4
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 claims 2
- HVRLZEKDTUEKQH-NOILCQHBSA-N Olopatadine hydrochloride Chemical group Cl.C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 HVRLZEKDTUEKQH-NOILCQHBSA-N 0.000 claims 2
- 208000036284 Rhinitis seasonal Diseases 0.000 claims 2
- 239000013566 allergen Substances 0.000 claims 2
- 208000027993 eye symptom Diseases 0.000 claims 2
- 229960002744 mometasone furoate Drugs 0.000 claims 2
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 claims 2
- 229960003139 olopatadine hydrochloride Drugs 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 208000017022 seasonal allergic rhinitis Diseases 0.000 claims 2
- 238000010181 skin prick test Methods 0.000 claims 2
- 241000282412 Homo Species 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000011859 microparticle Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3174MUM2013 | 2013-10-04 | ||
| IN3174MU2013 | 2013-10-04 | ||
| PCT/IB2014/065035 WO2015049665A1 (en) | 2013-10-04 | 2014-10-03 | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018076047A Division JP6768733B2 (ja) | 2013-10-04 | 2018-04-11 | モメタゾンおよびオロパタジンの組み合わせを使用するアレルギー性鼻炎の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016531949A JP2016531949A (ja) | 2016-10-13 |
| JP2016531949A5 true JP2016531949A5 (https=) | 2016-11-24 |
| JP6419195B2 JP6419195B2 (ja) | 2018-11-07 |
Family
ID=51982657
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016546191A Active JP6419195B2 (ja) | 2013-10-04 | 2014-10-03 | モメタゾンおよびオロパタジンの組み合わせを使用するアレルギー性鼻炎の治療 |
| JP2018076047A Active JP6768733B2 (ja) | 2013-10-04 | 2018-04-11 | モメタゾンおよびオロパタジンの組み合わせを使用するアレルギー性鼻炎の治療 |
| JP2020028523A Pending JP2020097624A (ja) | 2013-10-04 | 2020-02-21 | モメタゾンおよびオロパタジンの組み合わせを使用するアレルギー性鼻炎の治療 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018076047A Active JP6768733B2 (ja) | 2013-10-04 | 2018-04-11 | モメタゾンおよびオロパタジンの組み合わせを使用するアレルギー性鼻炎の治療 |
| JP2020028523A Pending JP2020097624A (ja) | 2013-10-04 | 2020-02-21 | モメタゾンおよびオロパタジンの組み合わせを使用するアレルギー性鼻炎の治療 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10646500B2 (https=) |
| EP (2) | EP4272839A3 (https=) |
| JP (3) | JP6419195B2 (https=) |
| CN (2) | CN105792828A (https=) |
| HK (1) | HK1215674A1 (https=) |
| MX (2) | MX2015009429A (https=) |
| MY (1) | MY176808A (https=) |
| PH (1) | PH12015502302A1 (https=) |
| RU (1) | RU2686670C2 (https=) |
| UA (1) | UA120587C2 (https=) |
| WO (1) | WO2015049665A1 (https=) |
| ZA (1) | ZA201504740B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9937189B2 (en) | 2013-09-13 | 2018-04-10 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| US9370483B2 (en) | 2013-09-13 | 2016-06-21 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| CN105792828A (zh) * | 2013-10-04 | 2016-07-20 | 格兰马克药品有限公司 | 使用莫米松和奥洛他定的组合治疗过敏性鼻炎 |
| US10653661B2 (en) | 2013-10-04 | 2020-05-19 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10758550B2 (en) | 2013-10-04 | 2020-09-01 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10548907B2 (en) | 2013-10-04 | 2020-02-04 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10016443B2 (en) | 2013-10-04 | 2018-07-10 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US11679210B2 (en) | 2014-10-03 | 2023-06-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
| EP3468532B1 (en) * | 2017-06-28 | 2020-09-23 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
| HUE071622T2 (hu) * | 2018-02-23 | 2025-09-28 | Glenmark Specialty Sa | Allergiás Rhinitis kezelése gyermekgyógyászati alanyoknál mometazon és olopatadin kombinációjával |
| US12303635B2 (en) | 2018-04-16 | 2025-05-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923892A (en) | 1985-08-17 | 1990-05-08 | Burroughs Wellcome Co. | Tricyclic aromatic compounds |
| GB8520662D0 (en) | 1985-08-17 | 1985-09-25 | Wellcome Found | Tricyclic aromatic compounds |
| US6127353A (en) | 1991-09-06 | 2000-10-03 | Schering Corporation | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| US5837699A (en) * | 1994-01-27 | 1998-11-17 | Schering Corporation | Use of mometasone furoate for treating upper airway passage diseases |
| PE44995A1 (es) | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
| ES2284531T3 (es) | 1999-10-08 | 2007-11-16 | Schering Corporation | Tratamiento nasal topico usando desloratadina y furoato de mometasona. |
| US7977376B2 (en) | 2001-06-27 | 2011-07-12 | Novartis Ag | Olopatadine formulations for topical nasal administration |
| JP2006508138A (ja) * | 2002-11-12 | 2006-03-09 | アルコン，インコーポレイテッド | アレルギー性鼻炎を処置するための抗アレルギー剤およびステロイドの使用 |
| US8912174B2 (en) | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
| MX2007005845A (es) | 2004-11-24 | 2007-07-04 | Alcon Inc | Metodo para entregar rocio nasal. |
| PL1919450T3 (pl) | 2005-09-01 | 2014-11-28 | Meda Ab | Kompozycja liposomowa zawierająca lek przeciwhistaminowy i kortykosteroid oraz jej zastosowanie do wytwarzania leku do leczenia nieżytu nosa i chorób spokrewnionych |
| CA2631757A1 (en) | 2005-12-02 | 2007-06-07 | Elan Pharma International Limited | Novel mometasone compositions and methods of making and using the same |
| DK2014305T3 (en) | 2006-04-21 | 2017-10-16 | Toko Yakuhin Kogyo Kk | SPRAYABLE GEL-SHAPED SKIN / MOSPHONE ADHESIVE AND ADMINISTRATIVE SYSTEM FOR USING THE PREPARATION |
| CN106038481A (zh) * | 2007-06-28 | 2016-10-26 | 锡德克斯药物公司 | 皮质类固醇水溶液的鼻部和眼部给药 |
| KR20110045004A (ko) | 2008-07-15 | 2011-05-03 | 쉐링 코포레이션 | 충혈제거제 및 코르티코스테로이드를 포함하는 비강내 조성물 |
| US8642069B2 (en) | 2008-08-27 | 2014-02-04 | Alexander D. Goldin | Composition and method for treating colds |
| PL2453872T3 (pl) | 2009-07-17 | 2013-12-31 | Alcon Res Ltd | Olopatadyna w postaci spreju do donosowego podawania dzieciom |
| CN102078326A (zh) * | 2009-11-26 | 2011-06-01 | 天津金耀集团有限公司 | 含有聚维酮碘与糠酸莫米松的局部使用组合物 |
| CN102078285A (zh) * | 2009-11-26 | 2011-06-01 | 天津金耀集团有限公司 | 含有皮质激素和h1受体拮抗剂的鼻用原位凝胶 |
| WO2011141929A2 (en) | 2010-05-11 | 2011-11-17 | Cadila Healthcare Limited | Aqueous pharmaceutical compositions of fluticasone and olopatadine |
| WO2012094283A2 (en) | 2011-01-04 | 2012-07-12 | Ista Pharmaceuticals, Inc. | Bepotastine compositions |
| MX2015005081A (es) | 2012-10-25 | 2015-07-17 | Novozymes As | Metodo mejorado para el lavado manual de la vajilla. |
| KR20140081925A (ko) * | 2012-12-12 | 2014-07-02 | 한미약품 주식회사 | 코르티코스테로이드, 항히스타민제 및 스테비아를 포함하는 고미 차폐된 약학 제제 |
| US9370483B2 (en) | 2013-09-13 | 2016-06-21 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| MX367674B (es) | 2013-09-13 | 2019-08-30 | Glenmark Specialty Sa | Composición farmacéutica de dosis fija estable que comprende mometasona y olopatadina. |
| CN105792828A (zh) * | 2013-10-04 | 2016-07-20 | 格兰马克药品有限公司 | 使用莫米松和奥洛他定的组合治疗过敏性鼻炎 |
-
2014
- 2014-10-03 CN CN201480066538.0A patent/CN105792828A/zh active Pending
- 2014-10-03 JP JP2016546191A patent/JP6419195B2/ja active Active
- 2014-10-03 US US14/506,122 patent/US10646500B2/en active Active
- 2014-10-03 WO PCT/IB2014/065035 patent/WO2015049665A1/en not_active Ceased
- 2014-10-03 MY MYPI2015702416A patent/MY176808A/en unknown
- 2014-10-03 MX MX2015009429A patent/MX2015009429A/es active IP Right Grant
- 2014-10-03 HK HK16103630.2A patent/HK1215674A1/zh unknown
- 2014-10-03 UA UAA201507124A patent/UA120587C2/uk unknown
- 2014-10-03 CN CN202110299649.8A patent/CN112773808A/zh active Pending
- 2014-10-03 EP EP23198254.7A patent/EP4272839A3/en active Pending
- 2014-10-03 RU RU2015128496A patent/RU2686670C2/ru active
- 2014-10-03 EP EP14802944.0A patent/EP2922553B1/en active Active
-
2015
- 2015-07-01 ZA ZA2015/04740A patent/ZA201504740B/en unknown
- 2015-07-22 MX MX2020003035A patent/MX2020003035A/es unknown
- 2015-10-05 PH PH12015502302A patent/PH12015502302A1/en unknown
-
2018
- 2018-04-11 JP JP2018076047A patent/JP6768733B2/ja active Active
-
2020
- 2020-02-21 JP JP2020028523A patent/JP2020097624A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016531949A5 (https=) | ||
| Pham et al. | Strategies for the design of orally bioavailable antileishmanial treatments | |
| JP2016523862A5 (https=) | ||
| MX2017003102A (es) | Formulacion para inhalacion liquida que comprende rpl554. | |
| ME02841B (me) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| JP2017506624A5 (https=) | ||
| EA201890196A1 (ru) | Композиция для устранения заложенности носа, обладающая противовирусным действием | |
| BR112015018252A2 (pt) | composição farmacêutica aquosa de dose fixa estável para administração nasal para um ser humano, composição de suspensão aquosa farmacêutica de dose fixa estável para administração nasal para um ser humano, suspensão estável adequada para administração nasal a um ser humano, método para tratar rinite em um ser humano necessitando do mesmo, uso da composição farmacêutica para administração nasal, método para liberar uma composição farmacêutica e kit | |
| RU2015128496A (ru) | Лечение аллергического ринита с использованием комбинации мометазона и олопатадина | |
| DOP2022000093A (es) | Inhibidores de adrenoreceptor adrac2 | |
| BR112015014174A2 (pt) | composição de vacina para indivíduos virgens | |
| EP3424512A4 (en) | USE OF ALGIN SULFATE IN THE MANUFACTURE OF MEDICAMENTS AND HEALTH CARE PRODUCTS FOR THE PREVENTION AND TREATMENT OF ILLNESSES DUE TO HUMAN PAPILLOMA VIRUSES | |
| JP2017505809A5 (https=) | ||
| JP2016502991A5 (https=) | ||
| RU2015121039A (ru) | Комбинация левокабастина и флутиказона фуроата для лечения воспалительных и/или аллергических состояний | |
| JP2014520874A5 (https=) | ||
| MX2018013475A (es) | Acido carboxilico para tratar/prevenir congestion nasal. | |
| JP2019529569A5 (https=) | ||
| JP2017061488A5 (https=) | ||
| JP2016175884A5 (https=) | ||
| WO2018093237A3 (ko) | 포름산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 | |
| JP2016525147A5 (https=) | ||
| HRP20250411T1 (hr) | Liječenje alergijskog rinitisa kod pedijatrijskih subjekata kombinacijom mometazona i olopatadina | |
| JP2015533131A5 (https=) | ||
| MX2017001900A (es) | Composicion nasal con capacidades de formacion de pelicula. |